canrenoic acid has been researched along with Esophageal Varices in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boari, G; Calchera, I; Dell'Oro, R; Favini, G; Grassi, G; Mancia, G; Pozzi, M; Ratti, L; Redaelli, E | 1 |
Arena, U; Ascione, A; Bernardi, M; Bolondi, L; Donati, G; FerraĆ¹, O; Gatta, A; Gentilini, P; Mazzanti, R; Piscaglia, F; Sacerdoti, D; Salerno, F; Trevisani, F; Visentin, S | 1 |
2 trial(s) available for canrenoic acid and Esophageal Varices
Article | Year |
---|---|
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
Topics: Adrenergic Fibers; Canrenoic Acid; Case-Control Studies; Diastole; Esophageal and Gastric Varices; Female; Heart; Heart Ventricles; Hemodynamics; Hepatic Veins; Hepatitis B; Hepatitis C; Humans; Liver Circulation; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Peroneal Nerve; Portal System; Stroke Volume; Venous Pressure | 2005 |
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
Topics: Aged; Ascites; Canrenoic Acid; Disease Progression; Double-Blind Method; Esophageal and Gastric Varices; Female; Humans; Incidence; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists | 2006 |